Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Blood
|
November 26, 1999
Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821
S C Raimondi, M N Chang, Y Ravindranath, et al.
Biochemical and Biophysical Research Communications
|
August 30, 1989
The inhibition of cytoplasmic acetoacetyl-CoA thiolase by a triyne carbonate (L-660, 631)
M D Greenspan, J B Yudkovitz, J S Chen, et al.
The New England Journal of Medicine
|
May 30, 1996
Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group
Y Ravindranath, A M Yeager, M N Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1985
Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects
T Y Shen, S B Hwang, M N Chang, et al.
Leukemia
|
May 3, 2002
Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia
N J Lacayo, B L Lum, D L Becton, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
May 1, 1991
Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeys
K L Thomson, M N Chang, R L Bugianesi, et al.
Blood
|
August 10, 1999
Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin
J W Taub, X Huang, L H Matherly, et al.
Journal of Medicinal Chemistry
|
March 1, 1990
Antioxidant-based inhibitors of leukotriene biosynthesis. The discovery of 6-[1-[2-(hydroxymethyl)phenyl]-1-propen-3-yl]-2,3-dihydro-5- benzofuranol, a potent topical antiinflammatory agent
M L Hammond, R A Zambias, M N Chang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1988
Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes
K L Thompson, M N Chang, J C Chabala, et al.
Journal of Medicinal Chemistry
|
October 30, 1992
4-[2-[Methyl(2-phenethyl)amino]-2-oxoethyl]-8-(phenylmethoxy)-2- naphthalenecarboxylic acid: a high affinity, competitive, orally active leukotriene B4 receptor antagonist
F C Huang, W K Chan, J D Warus, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Blood
|
November 26, 1999
Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821
S C Raimondi, M N Chang, Y Ravindranath, et al.
Biochemical and Biophysical Research Communications
|
August 30, 1989
The inhibition of cytoplasmic acetoacetyl-CoA thiolase by a triyne carbonate (L-660, 631)
M D Greenspan, J B Yudkovitz, J S Chen, et al.
The New England Journal of Medicine
|
May 30, 1996
Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group
Y Ravindranath, A M Yeager, M N Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1985
Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects
T Y Shen, S B Hwang, M N Chang, et al.
Leukemia
|
May 3, 2002
Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia
N J Lacayo, B L Lum, D L Becton, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
May 1, 1991
Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeys
K L Thomson, M N Chang, R L Bugianesi, et al.
Blood
|
August 10, 1999
Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin
J W Taub, X Huang, L H Matherly, et al.
Journal of Medicinal Chemistry
|
March 1, 1990
Antioxidant-based inhibitors of leukotriene biosynthesis. The discovery of 6-[1-[2-(hydroxymethyl)phenyl]-1-propen-3-yl]-2,3-dihydro-5- benzofuranol, a potent topical antiinflammatory agent
M L Hammond, R A Zambias, M N Chang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1988
Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes
K L Thompson, M N Chang, J C Chabala, et al.
Journal of Medicinal Chemistry
|
October 30, 1992
4-[2-[Methyl(2-phenethyl)amino]-2-oxoethyl]-8-(phenylmethoxy)-2- naphthalenecarboxylic acid: a high affinity, competitive, orally active leukotriene B4 receptor antagonist
F C Huang, W K Chan, J D Warus, et al.
Page
of 5